PIVA, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.553
AS - Asia 169
EU - Europa 135
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.858
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.553
CN - Cina 122
FI - Finlandia 52
VN - Vietnam 24
IT - Italia 22
SE - Svezia 21
IN - India 18
DE - Germania 13
GB - Regno Unito 12
UA - Ucraina 6
NL - Olanda 4
IE - Irlanda 3
TR - Turchia 2
BE - Belgio 1
EU - Europa 1
IL - Israele 1
LK - Sri Lanka 1
RU - Federazione Russa 1
TW - Taiwan 1
Totale 1.858
Salva come PNG Salva come JPEG
Città #
Fairfield 270
Woodbridge 169
Houston 147
Chandler 144
Ashburn 129
Ann Arbor 108
Seattle 103
Cambridge 88
Wilmington 85
Jacksonville 35
Helsinki 32
Princeton 31
Nanjing 29
San Diego 28
Dong Ket 24
Roxbury 21
Medford 20
Des Moines 17
Jinan 14
Boardman 9
Beijing 8
Changsha 8
Padova 8
Pune 8
Shenyang 8
Hebei 7
New York 7
Nanchang 6
Hefei 5
Tianjin 5
Guangzhou 4
London 4
Dublin 3
Kunming 3
Norwalk 3
Redwood City 3
Renton 3
Baotou 2
Borås 2
Castelfranco Veneto 2
Delhi 2
Fuzhou 2
Jiaxing 2
Kilburn 2
Lanzhou 2
Marghera 2
Ningbo 2
Phoenix 2
Selvazzano Dentro 2
Taizhou 2
Zhengzhou 2
Agropoli 1
Amsterdam 1
Bolu 1
Boston 1
Bromley 1
Brussels 1
Chengdu 1
Edinburgh 1
Fisciano 1
Groningen 1
Holon 1
Los Angeles 1
Milan 1
Nutley 1
Pisa 1
Qingdao 1
Regensburg 1
Southwark 1
Taipei 1
Taiyuan 1
Wenzhou 1
Yenibosna 1
Totale 1.646
Salva come PNG Salva come JPEG
Nome #
A new turbidimetric standard to improve the quality assurance of the erythrocyte sedimentation rate measurement. 137
Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: A report of three cases 122
Length of sedimentation reaction in undiluted blood (erythrocyte sedimentation rate): Variations with sex and age and reference limits 113
Notification of abnormal and critical values: the road ahead. 105
Adverse reactions in patients with B-cell lymphomas during combined treatment with rituximab: In vitro evaluation of rituximab hypersensitivity by basophil activation test. 102
Complete blood count at the ED: Preanalytic variables for hemoglobin and leukocytes 101
An immunological evaluation of type II diabetic patients with periodontal disease. 86
Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents 84
From "panic" to "critical" values: which path toward harmonization? 83
Critical results communication: still an open issue. 82
Phagocytic activity of bronchoalveolar lavage neutrophils in intensive care unit patients on mechanical ventilation. 78
Laboratory critical values: automated notification supports effective clinical decision making. 77
Clinical utility of reticulocyte parameters. 76
Observational retrospective study of vascular modulator changes during treatment in essential thrombocythemia 74
The role of automated analyzers in detecting abnormal granulation of leucocytes in lysosomal storage diseases: Maroteaux-Lamy disease. 74
Determination of the length of sedimentation reaction (erythrocyte sedimentation rate) in non-anticoagulated blood with the Microtest 1 70
Jordans' anomaly in a new neutral lipid storage disease. 65
Performance specifications of critical results management 58
Evaluation of new prognosis marker in B-CLL 55
Laboratory Critical Values Should Support Effective Clinical Decision Making 43
Erythrocyte sedimentation rate - Use of fresh blood for quality control 41
More study needed - The authors' reply 41
A case of eosinophilic disorder that evolved in acute lymphoblastyc leukemia. 40
Critical laboratory results: communication is just one of the problems. 37
Cllu1 Expression As A New Prognostic Marker In B-cell Chronic Lymphocytic Leukemia 28
Totale 1.872
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.437
article - articoli 6.156
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.593
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019191 0 0 0 0 0 0 0 0 0 34 76 81
2019/2020423 58 10 9 21 41 28 38 61 42 69 32 14
2020/2021293 19 19 18 11 6 33 23 26 51 18 30 39
2021/2022332 11 53 42 18 10 13 22 33 10 7 39 74
2022/2023277 49 44 1 33 43 32 0 19 38 1 7 10
2023/202494 8 15 8 9 21 20 7 4 0 2 0 0
Totale 1.872